ELITE PHARMACEUTICALS INC /NV/ 8-K

What Happened
Elite Pharmaceuticals, Inc. (ELTP) filed its annual report on Form 10-K for the fiscal year ended March 31, 2026, on June 29, 2026, and furnished a press release announcing its year‑end financial results (Exhibit 99.1). The company will host a conference call to discuss results and provide a general business update on Tuesday, June 30, 2026 at 11:30 AM Eastern Daylight Time.

Key Details

• Form 10-K filed: June 29, 2026 for fiscal year ended March 31, 2026.
• Investor conference call: June 30, 2026 at 11:30 AM EDT; domestic dial-in 1-800-346-7359, international 1-973-528-0008, conference number 98840.
• Questions: Submit to [email protected]; financial questions due by 7:00 PM EDT on June 29, 2026.
• Press release furnished as Exhibit 99.1; audio replay available at https://elite.irpass.com/events_presentations.
• The filing includes Regulation FD disclosure language and notes the furnished materials generally are not deemed “filed” for Section 18 liability or automatically incorporated by reference.

Why It Matters
Filing the Form 10-K and issuing a results press release provide investors with the company’s audited annual disclosures and management’s summary of fiscal year 2026 performance—key documents for evaluating revenue, earnings, cash flow and risks. The scheduled call gives shareholders an opportunity to hear management’s update and submit questions in advance. Review the Form 10-K and the press release (Exhibit 99.1) for the specific financial figures and details referenced in this notice.